GLOW BPC 157 10mg + GHK-CU 50mg + TB500 10mg

What is "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg?

"Glow" is a multi-peptide research blend combining three synthetic peptides: BPC-157, GHK-CU, and TB500. Each component has been independently studied for its potential roles in cellular protection, tissue remodeling, and biological regulation. The formulation includes 10 mg of BPC-157, 50 mg of GHK-CU, and 10 mg of TB500, provided as a lyophilized powder for controlled laboratory use. CAS Numbers

• BPC-157: 137525-51-0
• GHK-Cu: 49557-75-7
• TB500: 885340-08-9

BPC-157 is a 15-amino acid pentadecapeptide (molecular weight: 1,419 Da) modeled after a naturally occurring gastric peptide with structural stability in biological environments. GHK-CU is a copper(II)-complexed tripeptide (molecular weight: ~401 g/mol) consisting of glycine-histidine-lysine chelated to copper ions, naturally present in human plasma. TB500 is a synthetic heptapeptide fragment (Ac-LKKTETQ; molecular weight: ~920 Da) derived from the actin-binding region of thymosin beta-4, a conserved protein involved in cytoskeletal organization and cell movement. Together, these peptides represent chemically stable, low-molecular-weight signaling molecules suitable for experimental use in cellular and preclinical research systems.

What are the key features of "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg?

The "Glow" blend is developed to support controlled research examining multi-pathway peptide interactions in cell-based and preclinical studies, leveraging the distinct biological targets of each component.

• High-Purity Research Formulation: Supplied as a lyophilized powder with identity and composition verified through HPLC and mass spectrometry, ensuring consistent laboratory performance and batch-to-batch reliability.
• Multi-Peptide Synergy: Three distinct peptides targeting complementary signaling pathways—nitric oxide and growth factor regulation (BPC-157), metalloprotein activity and redox signaling (GHK-CU peptide), and actin-binding dynamics (TB500)—enabling investigation of coordinated biological responses.
• Enhanced Stability: Freeze-dried formulation maintains peptide integrity during storage and transport, with protective packaging in sealed, research-grade vials designed to preserve sterility and purity.
• Flexible Experimental Design: Researchers investigating BPC 157 GHK CU TB500 blend interactions can employ this combination without requiring parallel administration protocols, simplifying multi-pathway mechanistic studies.
• Chemically Characterized: Each peptide undergoes rigorous analytical verification, including HPLC purification, mass spectrometry confirmation, and chromatographic purity assessment to ensure lot-specific quality documentation.
• For Laboratory Research Use Only: Designed strictly for controlled research environments and compliant laboratory practice with no therapeutic applications intended.

How is "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg synthesized?

The "Glow" blend is synthetically manufactured, allowing precise control of sequence fidelity and molecular structure. Each of the three peptides is produced by solid-phase peptide synthesis (SPPS), a standard method for short-peptide synthesis that ensures accurate chain assembly and minimizes impurities. After synthesis, each peptide component undergoes HPLC purification to confirm chromatographic purity and mass spectrometry analysis for precise molecular weight verification. This multi-stage analytical process confirms identity and validates batch consistency across production cycles. The peptides are then combined and processed through a freeze-drying step, which removes solvent and water while preserving peptide structure and biological characteristics. This lyophilization enhances long-term stability and protects the combined formulation during shipment and storage under appropriate conditions.

What is "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg being studied for? What are its possible benefits?

The "Glow" blend is being researched for its potential involvement in biological processes related to inflammation modulation, tissue repair mechanisms, angiogenesis (blood vessel formation), extracellular matrix regulation, and cellular cytoprotection. Studies on the individual components have explored their roles in cell migration, growth factor signaling, oxidative stress responses, and gene expression modulation. Research areas under investigation include:

• Cellular organization and structural maintenance through coordinated actin dynamics
• Metabolic activity regulation within connective-tissue environments
• Wound-related biochemical signaling pathways
• Copper-dependent enzymatic cascade activation
• Redox balance modulation

Additionally, researchers examine the peptide blend for its potential involvement in nitric oxide signaling, fibroblast activity, angiogenic pathway engagement, and immune cell regulation. These findings remain preliminary and are based on preclinical or in-vitro research systems. No clinical effectiveness has been established, and these observations do not constitute therapeutic claims or medical recommendations.

How does "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg work in research studies?

In laboratory environments, the "Glow" blend is examined for how each component influences distinct but overlapping cellular signaling pathways. BPC-157 has been studied for its potential interaction with nitric oxide synthase activity and vascular endothelial growth factor (VEGF) signaling, which regulate tissue organization and endothelial function through gene expression modulation rather than direct receptor activation. Meanwhile, GHK-CU peptide is of interest for its copper-binding properties, which may participate in metalloproteinase activity regulation and oxidative stress responses through copper-dependent antioxidant enzyme activation. TB500 is investigated for its association with actin polymerization dynamics and intracellular actin sequestration, which directly influences cell motility, differentiation, and structural reorganization. In combined studies, researchers explore models involving:

• Growth-factor response coordination
• Angiogenic signaling integration
• Protein synthesis and turnover modulation
• Cellular migration and organizational processes

These mechanisms are theoretical and based on early scientific literature rather than confirmed clinical effects. The combined formulation allows investigation of how these distinct pathways may interact within coordinated inflammatory and reparative biological systems.

What dosing information exists for "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg?

Dosing information for this blend comes from preclinical and in-vitro research involving the individual peptides. Concentrations vary widely based on study design, experimental endpoints, and research model selection. Published research has reported: BPC-157 has been studied at 0.5–2 µg/mL in cell culture systems and 150–375 µg in murine preclinical models. GHK-CU has been used at 1–10 nM (nanomolar) concentrations in molecular and dermatological assay systems. TB500 has been evaluated at 2–8 mg/week in certain animal research protocols. These data do not translate directly to human use, and no established or recommended human dosing exists. Researchers assessing the blend sometimes reference such ranges when planning experimental protocols for controlled in-vitro testing and preclinical investigation, but interpretation requires careful consideration of the specific research context and methodology.

How should "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg be stored and handled?

Lyophilized peptides retain stability at room temperature for brief periods (typically fewer than 7 days without desiccant protection), though -20°C storage is strongly recommended for extended stability exceeding one month. Alternatively, 2–8°C refrigeration is acceptable for shorter storage periods (weeks to a few months). After reconstitution with sterile water or an approved solvent, the solution must be refrigerated at 2–8°C and used within 14–30 days as specified in the research protocol or product documentation. Researchers should prepare and handle all materials using aseptic technique with appropriate sterile equipment, including gloves and protective laboratory equipment. Avoid repeated freeze-thaw cycles of reconstituted solutions, as temperature fluctuations may lead to peptide degradation and reduced biological activity. Store reconstituted preparations away from light and extreme temperature variations. Follow all institutional biosafety guidelines and disposal protocols when handling or discarding peptide materials, and always consult the Safety Data Sheet (SDS) provided with the product for comprehensive handling and safety information.

Where can I read more research about "Glow" BPC 157 10mg+GHK-CU 50mg+TB500 10mg?

Researchers can explore peer-reviewed studies on the individual peptides through the following sources:

1. Chang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014;19(11):19066-19077. Published 2014 Nov 19. doi:10.3390/molecules191119066
2. Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. doi:10.1155/2015/648108
3. Pickart L, Vasquez-Soltero JM, Margolina A. The human tripeptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging: implications for cognitive health. Oxid Med Cell Longev. 2012;2012:324832. doi:10.1155/2012/324832
4. Philp D, Goldstein AL, Kleinman HK. Thymosin beta4 promotes angiogenesis, wound healing, and hair follicle development. Mech Ageing Dev. 2004;125(2):113-115. doi:10.1016/j.mad.2003.11.005
5. Huff T, Müller CS, Otto AM, Netzker R, Hannappel E. beta-Thymosins, small acidic peptides with multiple functions. Int J Biochem Cell Biol. 2001;33(3):205-220. doi:10.1016/s1357-2725(00)00087-x

Compliance Statement

This product is intended for laboratory research use only and is not approved for human or veterinary use.